mehealth® at AAP Experience 2016

mehealth® at AAP Experience 2016

0 Comments

mehealth® at AAP Experience 2016

IXICO will be exhibiting its mehealth® technology at booth # 1139 at the American Academy of Pediatrics (AAP) National Conference & Exhibition. The event takes place from 22 – 25 October 2016 in San Francisco.


mehealth-logo-w=200IXICO’s Ken Tubman, VP Healthcare Technology, and Teri Doyschen, Product Support Specialist, will be at our exhibition stand (Booth #1139) discussing IXICO’s digital health solutions for psychiatric and neurological diseases, including the company’s mehealth® platform.

mehealth® integrates web-based and mobile technologies for clinicians, patients and care-givers for use in both clinical care and clinical trial settings. In clinical practice it allows care to be initiated and adapted according to the patients’ unique profile and evolving needs. The software has been used in the care of over 20,000 children with ADHD across the US and has been shown in a randomised trial to improve concordance with clinical guidelines. In clinical trials mehealth® enables the collection of data from multiple environments and informants, including the integration of remote monitoring wearables, smartphone applications and patient- and carer-facing web-based portals.

At the event the team will also be presenting the following poster which reports data from mehealth® ADHD demonstrating that the collection of longitudinal data relating children’s symptoms and impairments in more than one setting (school as well as home) improves ADHD outcomes.

Title: Web-Based Portal Demonstrates That Teacher Follow-Up Vanderbilt Assessments Improve ADHD Outcomes

Authorship: Ilan Shapiro, Robin Wolz, Janet Munro

mehealth® is being deployed by the American Academy of Pediatrics (AAP) as part of its Chapter Quality Network improvement program (See Press Release here).

To take this opportunity to meet with Ken or Teri please get in touch at INFO@MEHEALTH.COM.

Web-Based Technology Improves Pediatric ADHD Care and Patient Outcomes

0 Comments

Web-Based Technology Improves Pediatric ADHD Care and Patient Outcomes

IXICO plc (Ticker: IXI) (‘IXICO’ or the ‘Company’), the brain health company, is pleased to note a press release from Cincinnati Children’s a non-profit, pediatric, academic medical center. This release notes the publication of positive result in a peer-reviewed journal of a multi-institutional study examining the use of a new web-based software program to help to reduce ADHD behavioural symptoms in children. The web-based digital healthcare platform has been licensed to IXICO and is now available as a clinical decision support tool in the US from www.mehealthcom


See full release here

CINCINNATI – As cases of ADHD continue to rise among U.S. children, pediatricians at busy community practices are getting a much-needed assist from a web-based technology to improve the quality of ADHD care and improve patient outcomes.

According to a multi-institutional study published online July 26 in Pediatrics, a new webbased software program is helping reduce ADHD behavioral symptoms in children receiving care at community pediatric practices by coordinating care and ensuring patients get the most effective ADHD medication for their care.

This is important for children with ADHD who rely on extremely busy community based pediatric practices where ADHD care is often poor – especially in the areas of medication management and monitoring, according to Jeffery Epstein, PhD, the study’s principal investigator and director of the Center for ADHD at Cincinnati Children’s Hospital Medical Center.

“Our data show the software not only helped improve the quality of medication care received by children treated at community based pediatric practices, but it also improved treatment outcomes for these children,” Epstein said. “As a result of the improved quality of ADHD care, children treated by pediatricians using this new technology had significantly less ADHD symptoms than children treated by pediatricians who were not given access to this web-based technology.”

Read more

Optimal Medicine Inc. Renamed IXICO Technologies Inc.

0 Comments

Optimal Medicine Inc. Renamed IXICO Technologies Inc.

Today IXICO plc is pleased to announce that Optimal Medicine Inc. has been renamed IXICO Technologies Inc. with immediate effect.


 

See Full Press Release HereIXICO Logo

A key part of the Optimal Medicine acquisition on 8 December 2015 was to bring US infrastructure and IT Healthcare expertise. The renaming of the company to IXICO Technologies Inc is a final and important step in the integration of Optimal Medicine within the enlarged IXICO Group and reflects the Company’s plans to build the US presence under the leadership of Kenneth Tubman, who joined the Group management team as VP of Healthcare Technology.

The IXICO Technologies Inc. team are focused on developing and supporting IXICO’s mehealth® products and associated services in clinical decision support. They will:

  • Play a key role in supporting the mehealth® for ADHD technology pilot with the American Academy of Pediatrics (“AAP”) as part of its Chapter Quality Network improvement program (see full press release here);
  • Lead development of IXICO’s MyBrainBook® digital platform for patients with dementia as part of a number of NHS Testbed pilots (see full press release here); and
  • Lead the expansion of the mehealth® product into monitoring patients with dementia and the incorporation of wearable sensor technologies as part of IXICO’s Cygnus study (see full press release here).

 

mehealth® at American Psychiatric Association Annual Meeting

0 Comments

mehealth® at APA Annual Meeting 2016

Janet Munro, SVP of Clinical Science at IXICO, will be attending the American Psychiatric Association (APA) Annual Meeting in Atlanta from 14th-18th May 2016.


 

The event will host a variety of exhibitions, scientific and clinical reports sessions, seminars, symposia and workshops focusing on the future of psychiatry.  The conference will look at:

  • Describing new research findings in psychiatry and neuroscience and how they may impact practice
  • Applying quality improvement strategies to improve clinical care
  • Providing culturally competent care for diverse populations
  • Describing the utility of psychotherapeutic and pharmacological treatment options
  • Integrating knowledge of current psychiatry into discussions with patients
  • Identifying barriers to care, including health service delivery issues.

 

Janet will be attending the event to discuss IXICO’s digital health solutions for psychiatric and neurological diseases, including the company’s mehealth® platform. Mehealth integrates web-based and mobile technologies for clinicians, patients and care-givers for use in both clinical care and clinical trial settings. In clinical practice it allows care to be initiated and adapted according to the patients’ unique profile and evolving needs. The software has been used in the care of over 12,000 children with ADHD across the US and has been shown in a randomised trial to improve concordance with clinical guidelines. In clinical trials mehealth enables the collection of data from multiple environments and informants, including the integration of remote monitoring wearables, smartphone applications and patient- and carer-facing web-based portals.

Recently mehealth® was announced as being deployed by the American Academy of Pediatrics (AAP) as part of its Chapter Quality Network improvement program (See Press Release here).

To take this opportunity to meet with Janet please get in touch at JMUNRO@IXICO.COM.

 

mehealth at NAPNAP 2016

0 Comments

mehealth at NAPNAP 2016

mehealth will be exhibiting at the National Association of Pediatric Nurse Practitioners conference on March 16th-18th 2016 at Hyatt Regency, Atlanta.


The event will host a number of sessions and workshops covering a range of topics from ADHD and Primary Care, to Tools and Electronic Options for Behavioral/Mental Health Screening.

Alyssa Semple, Sales Executive, mehealth, will be at the event showcasing mehealth for ADHD – one of the products from the mehealth range.

mehealth is secure online software for clinicians at the point-of-care to support patient-centered, evidence-based decision making and improve the monitoring and treatment of patients.

mehealth for ADHD Logo mehealth for ADHD is an evidence-based, comprehensive and easy-to-use tool for improving the quality of ADHD care.

Find out more about mehealth for ADHD here.

 

To take this opportunity to meet with Alyssa please get in touch at Alyssa.Semple@mehealth.com.

mehealth® Deployed in American Academy of Pediatrics Program

0 Comments

mehealth for ADHD logo

IXICO’s mehealth® deployed in American Academy of Pediatrics quality improvement program for

ADHD patients

Improving pediatric care for children with ADHD in the US


3 March 2016, IXICO plc (Ticker: IXI) (‘IXICO’ or the ‘Company’), the brain health company, is pleased to announce that its mehealth® technology has been deployed by the American Academy of Pediatrics (“AAP”) as part of its Chapter Quality Network improvement program.

Download full press release here

AAP’s 2016 quality improvement program initiative aims to improve pediatric ADHD care and patient outcomes. Under this initiative, mehealth® for ADHD is being deployed to support pediatricians from six State Chapters in the diagnosis, evaluation, routine assessment and treatment of children with ADHD. It will be used also for the collection of care quality metrics and to assist with training.

Professor Derek Hill, Chief Executive of IXICO, commented:

“We are delighted to be participating in the AAP’s 2016 initiative, which is focused on the clinical management and care of children and families living with ADHD. We are proud to be working alongside leading partners who have a shared vision of using technology, knowledge and expertise to change the delivery of healthcare and bring meaningful benefits to patients. The prominence and size of the AAP provides a significant opportunity for our mehealth® for ADHD product.”

The clinical care provided to children with ADHD traditionally relies on parents and teachers completing extensive paper-based assessments. The mehealth® platform technology simplifies data collection and facilitates reduced assessment times with the potential for more accurate diagnoses and improved treatment monitoring. Digital healthcare tools enable  pediatricians to balance an ever increasing work load whilst delivering the highest standards of care.

A participating physician commented:

“Parents and teachers have found that completing paper based Vanderbilt Assessments can be frustrating and time consuming. The mehealth® for ADHD product helps to reduce this frustration as mobile data entry makes it convenient to provide inputs that the physician can use in the provision of care.”

Mobile Applications in Healthcare – Here to Stay

0 Comments

Mobile Applications in Healthcare – Here to Stay

mehealth pic

We at mehealth know that the future of care delivery relies on digital health. More and more healthcare providers are taking notice.
Case in point: Earlier this month The Wall Street Journal’s Laura Landro wrote a great piece on the use of mobile applications to help manage costly and complex medical conditions.

Landro reports that “Hospitals are developing new mobile apps to help patients manage serious medical conditions and feed information back to their doctors between visits, often in real time.”

In the article, she describes examples of the multi-faceted use of mobile health tools to:

  • Help patients adhere to HIV medications
  • Manage the symptoms of inflammatory bowel disease and asthma
  • Prevent repeat heart problems after a cardiovascular rehabilitation program

Interestingly, Landro writes: “Because they are prescribed by physicians and used under medical supervision, researchers say, they stand a better chance of being integrated into patients’ daily routines, compared with health apps that consumers download and use without their doctors’ involvement.

This statement is directly correlated to what we at mehealth have long known; when treating patients with complex conditions ( such as behavioral health disorders), so much of what informs doctors’ decision-making is dependent on what takes place while the patient is out of the office between ‘physical appointments’. Further, the ability of these tools to collect information in all settings makes them more likely to be adopted by the patient, as they are often not only willing, but thrilled to take a part in their own care delivery.

As Landro mentions, the true benefit of digital health apps is that clinicians can use these tools to answer questions and gather details that are often impossible to observe from brief 20-minute patient encounters. Since there are often weeks or months between appointments, being able to accurately collect this information provides a fuller, more comprehensive patient picture, answering important clinical queries such as “What were the immediate effects of the medication?” or “Could you rate how your symptoms have progressed over the past two weeks?”.

For an improved, inclusive care continuum to be a reality, the healthcare industry must realize the value of digital health technologies, such as apps, and further continue to dedicate time and resources to develop and use these tools. Kudos to Ms. Landro for her piece and all those who continue to join mehealth in advocating for our patients and the benefits that digital health provides.

 

A Good Read for Behavioral Healthcare Providers

0 Comments

A Good Read for Behavioral Healthcare Providers

43493904_s

When I scanned over the first paragraph, I knew that Jill Sederstrom’s article “Clinicians must turn evidence into practice” in Behavioral Healthcare was going to be a good read. So, I got myself a coffee and settled down to enjoy it; I was not disappointed. I recommend you read it too.

As researcher and a clinician, I have sat on both sides of the table in the struggle to create an evidence base that is robust and valid, but also able to inform clinical care. I understand the problem and I’m very pleased to see it so eloquently acknowledged and explored by the author, including interviews with Kelly Clark, MD, President-elect of the American Society of Addiction Medicine, and Melanie Smith, Licensed Mental Health Counselor and Program & Training Manager of the Renfrew Center in Florida.

Some key messages from the article:

  • With an emphasis on quality initiatives, the importance of evidence-based practice in behavioral healthcare is growing. Payers “will be evaluating whether facilities are embracing the latest evidence that has been shown to produce optimal patient outcomes. They want the most value for their healthcare dollar.”
  • Behavioral healthcare providers must be prepared or the next few years “will become very problematic” for them. But, incorporating evidence into care is not an easy process and it takes time. Facilities need to invest to “translate what’s discovered in a research setting into everyday practice”.
  • Evidence-based approaches give clinicians a framework based on empirical data. “We don’t really have a lot of ability to know in the long-term how our patients are doing, [and]…whether or not what we’re doing is the most effective and efficient way to help someone get better”, says Smith.
  • Clark points out that evidence-based medicine (or evidence-informed medicine) “lends itself to quality metrics that are population-based and allow clinicians and facilities to see an issue from a broader population-based perspective that provides bench marking opportunities.”
  • The clinical trials that are required to bring a drug or device to market often do not represent real world scenarios. Distilling information from claims data or other big data sources can provide “actionable intelligence for clinicians”. “There’s not a lot of information that’s practical and usable for me in my office…” Smith says.

So how can we bring evidence into care? Highlights of the Renfrew Centers’ successful approach are described in the article; they are trailblazing. There is also an opportunity for large and small behavioral healthcare provider organizations to implement evidence-based care without needing to be the pioneers.

As the CEO of a health IT company, I now wrestle with the challenge of helping clinicians (including those who don’t have the band-width to be trailblazers) to deliver evidence-informed medicine to each individual patient.

Digital health solutions are enabling the findings of research to be easily applied in clinical care; incidentally they are also generating a wealth of real-world data that in itself enriches the evidence base and our understanding of optimal treatments.

We can distill the evidence base and protocols derived from it into integrated software that clinicians can use at the point-of-care. We can then capture the clinical characteristics and the symptoms of each individual patient and map them (automatically) against those best-practice guidelines. This generates personalized care recommendations which enable clinicians and patients to together make evidence-informed treatment decisions. By monitoring an individual’s status both at and between clinical consultations (using remote technologies) we can track progress and treatment like never before. We can identify early when things are going awry and come back to the “electronic” protocols to guide care.

The growing database of clinical data generated allows an organization to explore concordance with quality measures and monitor outcomes at a population level. The improved understanding of optimal treatment practices improves care and ensures the best value for each healthcare dollar. That seems like good thing!

My cup of coffee’s finished. Thanks Jill Sederstrom for a great read.

Everybody’s Talkin’ Telehealth

0 Comments

Janet Munro, our CEO, has written an article featured in HIStalk Practice on telehealth as the topic is increasingly talked about.
histalk
Read Janet’s article in full here…

Mehealth supports October ADHD Awareness Month

0 Comments

Mehealth supports October ADHD Awareness Month

ADHDAwareness

It’s October 1st, which means that ADHD Awareness Month begins today!

More than anything, this month is a chance for us all to support what we know is true: ADHD can affect anyone, regardless of age, race, nationality, or income level. More importantly ADHD is not a debilitating issue, shouldn’t intimidate families, and can be managed successfully when parents, teachers, and pediatricians are able to work together.

To help do our part, mehealth has a full month of activities planned meant to raise awareness for this important cause:

  • The 31 days of ADHD Awareness: Follow our @mehealthADHD Twitter handle as we tweet out one ADHD fact per day. Be sure to RT and comment on our Tweets to help spread the message to as many people as possible!
  • Share your ADHD child’s artwork: Starting this week, we’ll be accepting artwork from children with ADHD to share on our Facebook Page. We will be posting your child’s drawings, paintings, sketches, etc. at the end of each week, so stay tuned for further instructions on how to submit!
  • Add an ADHD “Twibbon” to your profile: Make sure your Social Media profile is on board with ADHD Awareness month as well! Click the following link to add an official Twitter ribbon i.e. “Twibbon” showing your support for ADHD Awareness: Add a Twibbon here.
  • Succeeding with ADHD: On both our Facebook and Twitter Pages we will be sharing success stories of people who have not only overcome their ADHD symptoms, but thrived thanks to the unique characteristics common with the condition.
  • Friday Feedback: We want to hear your voice! Each Friday we’ll be asking questions on Facebook asking your opinion on important ADHD topics. Share your input on everything from parenting advice to proven tips and strategies for handling the everyday challenges of ADHD.

 

Most importantly…. Talk about ADHD! Parents, teachers and pediatricians can use Social Media to support and help reduce the stress and unknown. Share your successes not just on Social Media, but also in person and with your peers. This month is a chance to break down stigmas that still exist and make sure each of us doing our part to help, whether that means ensuring that pediatricians have the tools to properly assess ADHD, or simply being more open about discussing how the disorder affects individuals on a daily basis. We all must contribute to make a difference.